Dr Reddys Laboratories (RDY) Net Income (2009 - 2026)
Dr Reddys Laboratories (RDY) posted Net Income of $45.93 million for the quarter ended Jun 30, 2026, down 72.1% from $164.71 million a year earlier and down 98.1% from the prior quarter.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Net Income (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Income at Dr Reddys Laboratories was $4.44 billion, up 780.9% year-over-year; for the year ended Mar 31, 2026, it was $452 million, down 33.3% from the prior year.
- Annual Net Income shows a five-year compound annual growth rate of 13.9% (years ended Mar 2021 to Mar 2026).
- In prior years, Dr Reddys Laboratories' Net Income was $677.3 million in the year ended Mar 31, 2025 (+1.4%), $668 million in the year ended Mar 31, 2024 (+21.9%), $548 million in the year ended Mar 31, 2023 (+76.2%) and $311 million in the year ended Mar 31, 2022 (+31.8%).
- The figure for the quarter ended Jun 30, 2026 stands as the lowest quarterly Net Income since the quarter ended Mar 31, 2025.
- On a year-over-year basis, Net Income increased in two of the last five quarters, with growth averaging 176.6%.
- The strongest year-over-year quarter for Net Income in the past five years was the quarter ended Dec 31, 2025, with growth of 964.6%; the weakest was the quarter ended Dec 31, 2023, with a decline of 89.8%.
- According to Business Quant data, Net Income for the three prior quarters was $2.46 billion (quarter ended Mar 31, 2026), $1.77 billion (quarter ended Dec 31, 2025) and $163.58 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 3.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 2.51 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -237.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Dr Reddys Laboratories | 10.53 Bn | 9.72 Bn | 396.53 Mn | 45.93 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 45.93 Mn |
| Mar 31, 2026 | 2.46 Bn |
| Dec 31, 2025 | 1.77 Bn |
| Sep 30, 2025 | 163.58 Mn |
| Jun 30, 2025 | 164.71 Mn |
| Mar 31, 2025 | 12.63 Mn |
| Dec 31, 2024 | 166.26 Mn |
| Sep 30, 2024 | 160.17 Mn |
| Jun 30, 2024 | 166.87 Mn |
| Mar 31, 2024 | -6.71 Mn |
| Dec 31, 2023 | 11.91 Mn |
| Sep 30, 2023 | 179.04 Mn |
| Jun 30, 2023 | 178.00 Mn |
| Mar 31, 2023 | 169.00 Mn |
| Dec 31, 2022 | 117.00 Mn |
| Sep 30, 2022 | 152.00 Mn |
| Jun 30, 2022 | 154.01 Mn |
| Mar 31, 2022 | 11.64 Mn |
| Dec 31, 2021 | 48.00 Mn |
| Sep 30, 2021 | 93.00 Mn |
API Access
Dr Reddys Laboratories Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();